Cargando…
Histologic, Histomorphometric, and Clinical Analysis of the Effects of Growth Factors in a Fibrin Network Used in Maxillary Sinus Augmentation
This randomized controlled clinical trial evaluated the effect of mineralized plasmatic matrix (MPM), comprised of synthetic graft and platelet concentrates, on new bone formation and volume stability over time in maxillary sinus lifting (MSL). Unilateral MSL was performed in 20 patients with either...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142822/ https://www.ncbi.nlm.nih.gov/pubmed/32183498 http://dx.doi.org/10.3390/ijerph17061918 |
_version_ | 1783519469784530944 |
---|---|
author | Cinar, Ihsan Caglar Gultekin, Bahattin Alper Saglanmak, Alper Yalcin, Serdar Olgac, Vakur Mijiritsky, Eitan |
author_facet | Cinar, Ihsan Caglar Gultekin, Bahattin Alper Saglanmak, Alper Yalcin, Serdar Olgac, Vakur Mijiritsky, Eitan |
author_sort | Cinar, Ihsan Caglar |
collection | PubMed |
description | This randomized controlled clinical trial evaluated the effect of mineralized plasmatic matrix (MPM), comprised of synthetic graft and platelet concentrates, on new bone formation and volume stability over time in maxillary sinus lifting (MSL). Unilateral MSL was performed in 20 patients with either beta-tricalcium phosphate (β-TCP) or MPM grafts (10 sinuses each). Six months postsurgery, specimens were obtained with a trephine bur prior to implant placement in 39 cases. Volumetric changes in sinus augmentation were analyzed between 1 week (T-I) and 6 months (T-II) postsurgery. Histomorphometric and histological analyses of biopsy samples revealed mean new bone percentages of 35.40% ± 9.09% and 26.92% ± 7.26% and residual graft particle areas of 23.13% ± 6.16% and 32.25% ± 8.48% in the MPM and β-TCP groups, respectively (p < 0.05). The mean soft-tissue areas in the MPM and β-TCP groups were 41.48% ± 8.41% and 40.83% ± 8.86%, respectively (p > 0.05). Graft reductions between baseline and 6-months postprocedure in the β-TCP and MPM groups were 17.12% ± 13.55% and 14.41% ± 12.87%, respectively, with significant graft volume reduction observed in both groups (p < 0.05) while there is no significant difference between MPM and β-TCP groups (p > 0.05). Thus, MPM, representing growth factors in a fibrin network, increases new bone formation and has acceptable volume stability in MSL procedures |
format | Online Article Text |
id | pubmed-7142822 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71428222020-04-14 Histologic, Histomorphometric, and Clinical Analysis of the Effects of Growth Factors in a Fibrin Network Used in Maxillary Sinus Augmentation Cinar, Ihsan Caglar Gultekin, Bahattin Alper Saglanmak, Alper Yalcin, Serdar Olgac, Vakur Mijiritsky, Eitan Int J Environ Res Public Health Article This randomized controlled clinical trial evaluated the effect of mineralized plasmatic matrix (MPM), comprised of synthetic graft and platelet concentrates, on new bone formation and volume stability over time in maxillary sinus lifting (MSL). Unilateral MSL was performed in 20 patients with either beta-tricalcium phosphate (β-TCP) or MPM grafts (10 sinuses each). Six months postsurgery, specimens were obtained with a trephine bur prior to implant placement in 39 cases. Volumetric changes in sinus augmentation were analyzed between 1 week (T-I) and 6 months (T-II) postsurgery. Histomorphometric and histological analyses of biopsy samples revealed mean new bone percentages of 35.40% ± 9.09% and 26.92% ± 7.26% and residual graft particle areas of 23.13% ± 6.16% and 32.25% ± 8.48% in the MPM and β-TCP groups, respectively (p < 0.05). The mean soft-tissue areas in the MPM and β-TCP groups were 41.48% ± 8.41% and 40.83% ± 8.86%, respectively (p > 0.05). Graft reductions between baseline and 6-months postprocedure in the β-TCP and MPM groups were 17.12% ± 13.55% and 14.41% ± 12.87%, respectively, with significant graft volume reduction observed in both groups (p < 0.05) while there is no significant difference between MPM and β-TCP groups (p > 0.05). Thus, MPM, representing growth factors in a fibrin network, increases new bone formation and has acceptable volume stability in MSL procedures MDPI 2020-03-15 2020-03 /pmc/articles/PMC7142822/ /pubmed/32183498 http://dx.doi.org/10.3390/ijerph17061918 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Cinar, Ihsan Caglar Gultekin, Bahattin Alper Saglanmak, Alper Yalcin, Serdar Olgac, Vakur Mijiritsky, Eitan Histologic, Histomorphometric, and Clinical Analysis of the Effects of Growth Factors in a Fibrin Network Used in Maxillary Sinus Augmentation |
title | Histologic, Histomorphometric, and Clinical Analysis of the Effects of Growth Factors in a Fibrin Network Used in Maxillary Sinus Augmentation |
title_full | Histologic, Histomorphometric, and Clinical Analysis of the Effects of Growth Factors in a Fibrin Network Used in Maxillary Sinus Augmentation |
title_fullStr | Histologic, Histomorphometric, and Clinical Analysis of the Effects of Growth Factors in a Fibrin Network Used in Maxillary Sinus Augmentation |
title_full_unstemmed | Histologic, Histomorphometric, and Clinical Analysis of the Effects of Growth Factors in a Fibrin Network Used in Maxillary Sinus Augmentation |
title_short | Histologic, Histomorphometric, and Clinical Analysis of the Effects of Growth Factors in a Fibrin Network Used in Maxillary Sinus Augmentation |
title_sort | histologic, histomorphometric, and clinical analysis of the effects of growth factors in a fibrin network used in maxillary sinus augmentation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142822/ https://www.ncbi.nlm.nih.gov/pubmed/32183498 http://dx.doi.org/10.3390/ijerph17061918 |
work_keys_str_mv | AT cinarihsancaglar histologichistomorphometricandclinicalanalysisoftheeffectsofgrowthfactorsinafibrinnetworkusedinmaxillarysinusaugmentation AT gultekinbahattinalper histologichistomorphometricandclinicalanalysisoftheeffectsofgrowthfactorsinafibrinnetworkusedinmaxillarysinusaugmentation AT saglanmakalper histologichistomorphometricandclinicalanalysisoftheeffectsofgrowthfactorsinafibrinnetworkusedinmaxillarysinusaugmentation AT yalcinserdar histologichistomorphometricandclinicalanalysisoftheeffectsofgrowthfactorsinafibrinnetworkusedinmaxillarysinusaugmentation AT olgacvakur histologichistomorphometricandclinicalanalysisoftheeffectsofgrowthfactorsinafibrinnetworkusedinmaxillarysinusaugmentation AT mijiritskyeitan histologichistomorphometricandclinicalanalysisoftheeffectsofgrowthfactorsinafibrinnetworkusedinmaxillarysinusaugmentation |